dRYBP Contributes to the Negative Regulation of the Drosophila Imd Pathway by Aparicio, Ricardo et al.
dRYBP Contributes to the Negative Regulation of the
Drosophila Imd Pathway
Ricardo Aparicio1., Claudine Neyen2., Bruno Lemaitre2, Ana Busturia1*
1Centro de Biologı´a Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientı´ficas and Universidad Auto´noma de Madrid, Madrid, Spain, 2Global Health
Institute, School of Life Sciences, E´cole Polytechnique Fe´de´rale de Lausanne, Lausanne, Switzerland
Abstract
The Drosophila humoral innate immune response fights infection by producing antimicrobial peptides (AMPs) through the
microbe-specific activation of the Toll or the Imd signaling pathway. Upon systemic infection, the production of AMPs is
both positively and negatively regulated to reach a balanced immune response required for survival. Here, we report the
function of the dRYBP (drosophila Ring and YY1 Binding Protein) protein, which contains a ubiquitin-binding domain, in the
Imd pathway. We have found that dRYBP contributes to the negative regulation of AMP production: upon systemic infection
with Gram-negative bacteria, Diptericin expression is up-regulated in the absence of dRYBP and down-regulated in the
presence of high levels of dRYBP. Epistatic analyses using gain and loss of function alleles of imd, Relish, or skpA and dRYBP
suggest that dRYBP functions upstream or together with SKPA, a member of the SCF-E3-ubiquitin ligase complex, to repress
the Imd signaling cascade. We propose that the role of dRYBP in the regulation of the Imd signaling pathway is to function
as a ubiquitin adaptor protein together with SKPA to promote SCF-dependent proteasomal degradation of Relish. Beyond
the identification of dRYBP as a novel component of Imd pathway regulation, our results also suggest that the evolutionarily
conserved RYBP protein may be involved in the human innate immune response.
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Introduction
Biological pathways involved in stress responses, like those
associated with innate immunity, must quickly and efficiently
modulate gene expression to ensure survival of the organism.
Drosophila uses the evolutionarily conserved host defense of innate
immunity to protect against microbial infection and relies mainly
on the Toll and Imd pathways to regulate the expression of
different AMP genes (for recent reviews see [1–3]). AMPs are
constitutively expressed in immuno-competent epithelial tissues to
defend the body against infection [4,5]. Furthermore, upon
systemic microbial infection the Toll and Imd pathways up-
regulate AMP production by the fat body and blood cells. Once
the infection is controlled, AMP expression is down-regulated to
avoid deleterious immuno-pathological reactions [6].
The Imd signaling pathway is activated by infection with Gram-
negative bacteria and Gram-positive bacilli [7]. The activation is
initiated upon detection of peptidoglycan (PGN) by PGRP-LC, a
member of the peptidoglycan recognition proteins, at the plasma
membrane [7–9]. Transduction of this signal requires ligand-
induced receptor oligomerization with subsequent assembly of a
signaling complex containing IMD, DREDD, and dFADD
receptor associated proteins [2,10–12]. The activation of this
pathway leads to the post-translational modification of the
Drosophila NF-kB factor Relish, and its nuclear translocation
[13]. Relish ultimately drives transcription of IMD-specific AMP
genes such as Diptericin and Attacin-B as well as several regulatory
Imd pathway components.
Regulation of NF-kB pathway activity in both invertebrates and
vertebrates is achieved at multiple levels through ubiquitin-
mediated post-translational modification of signaling components
[14,15]. In Drosophila, selective linkage of mono- or poly-ubiquitin
chains triggering degradation or stabilization of Imd pathway
components plays a crucial role in maintaining a balanced
immune response. IMD first undergoes cleavage by the caspase
DREDD, which itself is activated by poly-ubiquitylation [16,17].
The cleaved IMD protein is then tagged with K63-linked poly-
ubiquitin chains by the E3 ligase dIAP2 in complex with E2
conjugases Uev1a, dUbc13/Bendless and Effete [17,18], and
ubiquitylated IMD acts as an assembly platform for downstream
adaptors TAB2/dTAK1 [19]. Subsequent editing of K63- to K48-
linked ubiquitin chains through the ubiquitin hydrolase dUsp36
ends signaling by targeting IMD for proteasomal degradation [20].
As in vertebrates, ubiquitylation/deubiquitylation events also
regulate stability of the Drosophila IKK complex (ird5/key)
[19,21–23]. DREDD-mediated cleavage of Relish is thought to
be held in check by Caspar, a protein with multiple ubiquitin-
related domains [24], and by DNR1, a RING-domain containing
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protein which binds to DREDD and has been proposed to target it
for proteasomal degradation [25]. Finally, both intact and
processed Relish has been suggested to undergo ubiquitin-
mediated degradation through SKPA, a member of the E3-
ubiquitin ligase SCF complex [26].
The dRYBP (drosophila Ring and YY1 Binding Protein) gene [27]
encodes a protein that is evolutionarily conserved in vertebrates
(known as RYBP/DEDAF/YAF2) and that contains in its N-
terminus a ubiquitin-binding domain of the NZF (Nucleoporin
Zinc Finger) type [28]. Studies both in vertebrates and Drosophila
have described the phenotypic effects of high and low levels of
dRYBP expression and also its interactions with several proteins
involved in a range of biological processes, including epigenetic
transcriptional regulation mediated by the Polycomb and trithorax
groups of proteins [27,29–34]. Human RYBP/DEDAF has been
shown to interact with DED (Death Effector Domain) containing
proteins [35,36] that mediate homotypic interactions important
for the assembly and activation of apoptotic and inflammatory
complexes [37]. In Drosophila, high levels of dRYBP induces
apoptosis in imaginal disc cells and this apoptosis is dependent on
dFADD and DREDD [31], two DED containing proteins [37]
also involved in the IMD-mediated immune response in Drosophila
[10–12].
In this work we show that dRYBP contributes to the negative
regulation of the Imd signaling pathway. Notably, we have found
that dRYBP is required for the inhibition of the production of
AMPs upon systemic infection. We propose that dRYBP functions
in the immune response to promote ubiquitin-dependent degra-
dation of IMD-pathway components, among those the Relish
protein.
Materials And Methods
Fly stocks
CantonS were used as control flies. dRYBP null allele stocks were
dRYBP1/CyO GFP and dRYBPD55/ CyO GFP [30]. Deficiencies
uncovering the dRYBP genomic region were Df(2R)BSC598 and
Df(2R)BSC787 (http://flybase.bio.indiana.edu). The GAL4 lines
used were c564-Gal4, en-Gal4, hs-Gal4 (http://flybase.bio.indiana.
edu). The UAS lines used were: UAS-dRYBP, UAS-dRYBPRNAi [30],
UAS-imd [38], UAS-skpARNAi (http://www.flyrnai.org/TRiP-
HOME.html), UAS-Relish-His-6 [39], pUASt-Venus-dRYBP (this
work). The UAS-VDRCRNAi lines [40] were obtained from
http://stockcenter.vdrc.at.
Adult infection
The Gram-negative entomopathogen Erwinia carotovora carotovora
15 (Ecc15), and the Gram-negative Escherichia coli (E. coli) were
grown overnight as shaking cultures in LB medium at 29uC (Ecc15)
and 37uC (E. coli) and pelleted to an OD600 of 200 (Ecc15) or to an
OD600 of 400 (E. coli). Systemic infection of flies was done by
pricking a needle dipped in a bacterial pellet into the thorax of 2–
5-day old adult females. Where appropriate, pathogens were heat-
killed at 95uC during 15 min.
Cloning and generation of transgenic flies
The coding sequence of dRYBP (BDGP DGC clone LD18758)
without start codon was cloned into pENTR-D-TOPO (Life
Technologies) using the following primers: Forward: 59-CACC-
GACAAGAAATCCTCGCCG- 39, Reverse: 59-
CTAACTCCGGCTGTCGTTG-39. The Gateway system (Life
Technologies) was used to generate the expression vector pUASt-
Venus-dRYBP. Transgenic flies were obtained following standard
procedures using white1118 flies as host.
Quantitative real-time PCR (qRT-PCR)
RNA was isolated from 10–15 adult female flies of appropriate
genotype. RNA extraction and RT reactions were performed as
previously described [31]. qRT-PCR was performed using
FastStart Universal SYBR Green MasterRox (Roche) in an
Applied Biosystems 7900 Sequence Detector System. Quantified
mRNA levels were expressed as relative fold change normalized to
RpL32. The sequences of the primers and their efficiencies (in
brackets) are the following:
RpL32 Forward: 59-GACGCTTCAAGGGACAGTATCTG-
39, Reverse: 59-AAACGCGGTTCTGCATGAG-39 (1,89); dRYBP
Forward: 59-CATGTTGACACCTGGCTCCTG-39, Reverse: 59-
CGAAGGTGATCGAGGAGAAC-39 (1,97) ; Dpt: Forward: 59-
GCTGCGCAATCGTTCTACT-39, Reverse: 59-
TGGTGGAGTGGGCTTCATG-39 (1,98) ; AttB Forward: 59-
CCTACAACAATGCTGGTCATGGT-39, Reverse: 59-CCTA-
CAACAATGCTGGTCATGGT-39 (2,03); Relish Forward: 59-
TTAGCGTGGCCAACACAATG-39, Reverse: 59-GAACTGC-
CATGTGGAGTGCAT-39 (1,98); PGRP-LC Forward: 59-
GCATTCAATGGTGGTCCCA-39 Reverse: 59-
CCGGATCTTCGTGTTTGGAG-39 (1,97); imd Forward: 59-
TTCGGCTCCGTCTACAACTT-39, Reverse: 59-GTGATC-
GATTATGGCCTGGT-39 (2,03); Dredd F: 59-
CAAAAGGTGGGCCTCTGCT Reverse: 59-GTAGGTGG-
CATCCGAGTGGT-39 (2,02); Tab-2 Forward: 59-TGTCATG-
GAGGAATGCGATC-39, Reverse: 59-GCTTCTGACGCTC-
GATAGTGG-39 (1,97); TAK1 Forward: 59-
GATCTGAGTCCCAGCGAAAGC-39, Reverse: 59-
CATCGCTCTTTGCGTTCGT-39 (1,96); ird-5 Forward: 59-
TAGTGATCCATTGGCGAAACC-39, Reverse: 59-
GCTTGGTGGCAATTTCACG-39 (1,96); skpA Forward: 59-
CTCCCGAGGAAATACGCAAG-39, Reverse: 59-
CGGGCGAAAAGTCCTTCTTA-39 (1,99); dIAP2 Forward: 59-
ATGCAAGGTATGCTTGGACGA-39, Reverse: 59-TGATTG-
CAGGTGGCCAAGT-39 (1,90)
Statistical analysis
The data from all the qRT-PCR experiments represent the
mean + SEM of three biological repeats with 10–15 individuals
per sample. For inter-assay comparability, values within each
experiment were routinely normalized to the wild type or relevant
other control at a given time point. Data were analyzed using
ANOVA with Bonferroni post-test.
Immuno-staining
Fat bodies from adult females were dissected in PBS, fixed in
4% paraformaldehyde and stained with either anti-dRYBP
antibody (1:100) [27] and biotinylated anti-rabbit antibody
(1:200) as previously described [31], or with rabbit-anti-GFP
(Interchim) followed by Alexa488-anti-rabbit (Molecular Probes)
and DAPI. Images were taken on either a Zeiss CDD microscope
or a Zeiss confocal microscope with a 40-fold oil-immersion
objective.
Results
Loss of dRYBP results in over-activation of the Imd
pathway
The phenotypes associated with null alleles of dRYBP indicate
that this gene plays a role in diverse biological processes [30]. We
performed a genetic screen to search for dRYBP interacting genes
and found a number of components of the Imd pathway (Fig. S1).
Therefore, we chose to analyze the possible involvement of dRYBP
in modulating the immune response to Gram-negative infection.
dRYBP Modulates Imd Pathway Signaling
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We investigated whether the dRYBP gene could be regulating the
expression of antimicrobial peptides (AMPs), which are always
induced upon activation of the immune response. mRNA
expression levels of Diptericin (Dpt), an AMP normally induced
upon activation of the Imd pathway [41], were measured by qRT-
PCR in dRYBP null adult flies [30]. In uninfected adult dRYBP
mutant flies, Dpt expression was not significantly altered compared
to the wild-type control (Fig. 1A, unchallenged). However, upon
infection with the Gram-negative bacterium Erwinia carotovora
carotovora 15 (Ecc15), Dpt expression was significantly increased
beyond wild type levels after 8 h of infection in dRYBP1and
dRYBPD55 homozygous mutant flies, as well as in flies of dRYBP1 or
dRYBPD55 genotype over dRYBP genomic deficiencies excluding
background effects (Fig. 1A, 8 hours). dRYBP mutants showed a
normal return to baseline at 24h after challenge (Fig 1A,
24 hours). Infection with another Gram-negative pathogen, E.coli,
gave similar results to Ecc15 (Fig. 1B). Moreover, the increase in
Dpt expression was dose dependent since dRYBP heterozygous
mutant flies showed an intermediate phenotype, suggesting that
one dose of dRYBP is insufficient to ensure wild type regulation
(Fig. 1A and C). Furthermore, expression of AttB, another IMD-
dependent AMP [42], was similarly affected by loss of dRYBP (Fig.
1D). Taken together, these results indicate that dRYBP functions as
a negative modulator of the IMD-mediated immune response.
The up-regulation of the Dpt expression observed in dRYBP
mutants prompted us to study whether high levels of dRYBP
expression were capable of repressing Dpt production. mRNA
levels of Dpt were measured in hs-Gal4;UAS dRYBP flies in the
presence or absence of Ecc15 infection. Fig. 1E shows that dRYBP
overexpression significantly reduced Dpt expression following 8 h
of infection. The reduction in Dpt expression in the presence of
high levels of dRYBP further supports the notion that dRYBP is
contributing to the negative regulation of the IMD-pathway
mediated immune response.
Figure 1. Genetic modulation of dRYBP expression levels affects AMP production. (A, B, C, D, E). (A) All tested dRYBP mutants show an
excessive immune response to Gram-negative infection. Adult females of indicated genotypes were left unchallenged (left panel) or infected by
pricking with Ecc15 (heat-killed at 95uC during 15 min) and collected at 8 h (middle panel) and 24 h (right panel) after infection for Diptericin (Dpt)
mRNA quantification. The complete data set (unchallenged, 8 h, 24 h) was analysed by two-way ANOVA with Bonferroni post-tests, using CanS as
control. (B) dRYBP mutants also show excessive Imd activation after infection with another Gram-negative pathogen, E. coli. Adult females of
indicated genotypes were treated as in (A). (C) Infection time-course in wild-type, heterozygous and homozygous dRYBPD55 mutants. Flies were
treated as in (A). (D) Loss of dRYBP affects at least two Imd-dependent antimicrobial peptides. mRNA levels of Attacin-B (AttB) were quantified after
infection as described in (A). (E) Overexpression of dRYBP reduces the Imd response to Gram-negative infection. Adult females were infected as in (A),
then were heat-shocked for 1 h at 37uC and collected at 8 h and 24 h after infection for quantification of Dpt mRNA levels. (F) dRYBP expression levels
are not affected by infection. Wild-type adult females were infected as in (A) and dRYBP mRNA levels were monitored over time. For all graphs, data
represent mean + SEM of at least 3 biological repeats, and asterisks denote the following p values: *, 0.01,p,0.05; **, 0.001,p,0.01; *** p,0.001;
ns, not significant.
doi:10.1371/journal.pone.0062052.g001
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Several negative regulators of the Imd pathway, including
PGRP-LF, Pirk and PGRP-LB, are induced upon Gram-negative
infection and form a negative feedback loop [43–47]. We therefore
tested whether dRYBP expression levels in adult flies were affected
by infection with Ecc15. mRNA levels of dRYBP, as measured by
qRT-PCR, were not significantly changed after either 8 h or 24 h
of infection (Fig. 1F). This result is in agreement with microarray
studies [48,49] and suggests that dRYBP-mediated regulation of
Dpt expression is not controlled at the level of its own transcription.
Expression of Imd pathway components in dRYBP mutant
flies
Because dRYBP has been suggested to function as a transcrip-
tional regulator together with the Polycomb and trithorax proteins
[27,30] we analyzed whether dRYBP could be involved in the
transcriptional regulation of canonical Imd pathway components.
For this, we quantified the mRNA levels of selected Imd pathway
components in homozygous dRYBP1 and dRYBPD55 mutant flies
both in unchallenged conditions and after 8 h of infection with
Ecc15. Expression levels of all Imd pathway components studied
were unaffected in dRYBP mutant flies compared to control CanS
flies, whether in unchallenged conditions (Fig. 2A) or after 8 h of
infection (Fig. 2B). Moreover, we also studied whether over-
expression of dRYBP affects the expression of the most
downstream component, Relish. Fig. 2C shows that high levels of
dRYBP do not influence Relish expression. These results indicate
that dRYBP-mediated repression of Dpt expression is not due to
dRYBP acting directly as a transcriptional repressor on canonical
Imd pathway genes.
dRYBP is expressed in the nucleus of fat body cells
We have previously shown that dRYBP is ubiquitously
expressed in the embryo and the imaginal discs of the larva and
localizes to the nuclei of cells [27]. We performed immuno-
staining with anti-dRYBP antibody (Fig. 3A) in fat body cells and
found that dRYBP is also present in the nuclei of this immuno-
competent tissue in wild type conditions, which is in agreement
with FlyAtlas data [50] (CG12190, http://www.flyatlas.org). Since
the Imd pathway includes both cytosolic and nuclear steps, we
asked whether dRYBP localized to any cellular compartment in
particular during infection. To this aim we constructed UAS-Venus-
dRYBP flies and used the c564-Gal4 line to drive Venus-dRYBP
expression specifically in the fat body where AMPs are highly up-
regulated in response to systemic infection [2]. As shown in Fig. 3B
and C, the subcellular localization of dRYBP in adult female fat
body cells was exclusively nuclear at 3 h after infection with Ecc15,
as shown by fluorescence intensity profiles across cells. This
suggests that either the putative dRYBP expression in the
cytoplasm is too low to be detected using this approach or that
dRYBP acts on nuclear Imd pathway components rather than
upstream cytosolic adaptors.
Epistatic relationships between dRYBP and components
of the Imd pathway
To delineate the hierarchical positioning of dRYBP in the Imd
signaling cascade, we studied whether overexpression of dRYBP
could repress Dpt expression when the pathway was activated by
forced expression of IMD or Relish, both of them activators of the
Imd cascade [13,38], or by decreasing the expression of skpA, a
known repressor of the Imd cascade [26]. The latter two seemed
particularly relevant based on their proven nuclear localization
and hence accessibility to dRYBP.
Activation of the Imd cascade by overexpression of IMD in hs-
Gal4,UAS-imd flies resulted in increased production of Dpt (Fig. 4A,
compare Dpt expression in hs-Gal4 vs hs-Gal4,UAS-imd flies) [38].
Furthermore, in hs-Gal4,UAS-imd/UAS-dRYBP flies, Dpt expression
Figure 2. Loss of dRYBP does not affect expression of canonical
Imd pathway components. (A) mRNA levels of indicated Imd
pathway components were quantified in wild-type and dRYBP mutant
flies under unchallenged conditions (A) or (B), 8 h after infection by
pricking with Ecc15. Data in (A) and (B) represent mean + SEM of two
pooled biological repeats. For each gene, expression is normalized to
expression in unchallenged (uc) CanS. No significant difference in gene
expression between wild-type and dRYBP mutants, by two-way ANOVA
with Bonferroni post-test. (C) Overexpression of dRYBP does not affect
Relish expression. Adult females were infected as in (B), then were heat-
shocked for 1 h at 37uC and collected at 8 h and 24 h after infection for
quantification of mRNA levels of the IMD-dependent transcription
factor Relish. Data represent mean + SEM of 3 biological repeats.
doi:10.1371/journal.pone.0062052.g002
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was repressed (Fig. 4A, compare Dpt expression in hs-Gal4,UAS-imd
vs hs-Gal4,UAS-imd/UAS-dRYBP). This inhibition is not due to
dilution of the GAL4 protein as the expression levels of both
dRYBP and imd were very similar in flies overexpressing a single
gene versus flies overexpressing both genes concomitantly (Fig. 4B,
C for controls of the dilution of the GAL4 protein). Therefore,
these results indicate that dRYBP functions either together with
the IMD protein or downstream of the IMD protein in the
regulation of the Imd pathway.
Activation of the Imd cascade by overexpression of Relish in hs-
Gal4/UAS-Relish flies increased the expression of Dpt (Fig. 4D,
compare Dpt expression in hs-Gal4 flies to hs-Gal4/UAS-Relish) [39].
However, Dpt expression was still diminished in hs-Gal4/UAS-
Relish;UAS-dRYBP flies (Fig. 4D, compare Dpt expression in hs-
Gal4/UAS-Relish to hs-Gal4/UAS-Relish;UAS-dRYBP and Fig. 4E for
Gal4 dilution). These results indicate that dRYBP functions either
together with Relish or downstream of Relish in the repression of
the Imdpathway.
Finally, inactivation of skpA increased Dpt expression (Fig. 4F,
compare Dpt expression in c564-Gal4 flies to c564-Gal4;UAS-
skpARNAi) [26]. However, overexpression of dRYBP in these
conditions did not affect the expression of Dpt (Fig. 4F, compare
Dpt expression in c564-Gal4;UAS-skpARNAi to c564-Gal4;UAS-
skpARNAi /UAS-dRYBP and Fig. 4G for controls of the dilution
of the GAL4 protein). These results indicate that dRYBP functions
either together with SKPA or upstream of SKPA to repress the
activation of the Imdpathway.
Taken together, our investigation into the epistatic relationships
between dRYBP and imd, Relish and skpA indicates that dRYBP
functions at the level of the ubiquitin E3-ligase SKPA to repress
the activation of the Imd pathway and suggest that the ubiquitin-
binding dRYBP may function together with SKPA in the
degradation of Relish to inhibit the immune response.
Discussion
A balanced response to infection requires the control of both
positive and negative regulation of the Toll and Imd immune
signaling pathways [2,3,6]. Activation of the pathways to combat
the infection through the production of AMPs is as important as
their repression since flies rapidly die when several negative
regulators of the Imd pathway are simultaneously deleted [51]. In
the last decades, investigations into the mechanisms of immune
responses in Drosophila have mainly focused on deciphering the
activation of AMP production. However, more recently research
interest has switched to inhibitors of the pathway, and with the
identification of multiple candidates a picture of the mechanisms
controlling negative regulation is emerging [6,20,23–25,43–
46,52]. Here we have introduced the dRYBP gene as a novel
player in the negative regulation of the Drosophila Imdpathway.
The dRYBP protein and its vertebrate ortholog RYBP/
DEDAF/YAF2 have been shown to interact with a diverse range
of proteins [27–30,33,34,53]. Both the fly and the vertebrate
proteins have been found to interact genetically and molecularly
[27–30,34] with the Polycomb group of proteins that maintain the
repressed gene transcriptional states by epigenetic mechanisms (for
recent reviews [54,55]). Our investigation into the mechanisms by
which dRYBP is acting on the Imd pathway indicates that dRYBP
does not control the expression of the canonical Imd pathway
genes transcriptionally (Fig. 2) suggesting that dRYBP does not
function as a Polycomb group protein in the regulation of the
immune response.
Notably, the dRYBP protein contains a ubiquitin binding
domain and vertebrate RYBP/DEDAF/YAF2 has been shown to
bind ubiquitylated proteins [28]. An increasing number of both
activating and regulatory Imd pathway components involve
ubiquitin-dependent modifications [16,19,20,26]. It seemed there-
Figure 3. dRYBP localizes to the nuclei of adult fat body cells. (A) dRYBP protein is expressed in the nuclei of fat body cells (arrows). (B) Flies
overexpressing Venus-dRYBP under the fat body specific driver c564-Gal4 were infected by pricking with Ecc15. Fat bodies were dissected 3 h after
infection, fixed and stained with anti-GFP antibody and DAPI. Images are representative of several UAS-Venus-dRYBP insertion lines. (C) Fluorescence
profile along arrow in (B) shows dRYBP is exclusively nuclear and excluded from nucleoli. AU (Arbitrary Units). Scale bar denotes 20 mm.
doi:10.1371/journal.pone.0062052.g003
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Figure 4. Epistatic relationships between dRYBP and components of the Imd pathway. (A) dRYBP acts downstream of IMD. Flies
overexpressing dRYBP, imd, or both under the control of a heat-shock-inducible promoter were kept at 18uC (OFF) or exposed to 37uC for 1 h, then
shifted to 29uC for 7 h (ON), at which point Dpt mRNA levels were assessed to measure Imd pathway activity. (B, C) Overexpression of multiple UAS
constructs does not lead to Gal4 dilution. (B) shows qRT-PCR quantification of mRNA levels of dRYBP expression. dRYBP expression is increased under
induced conditions (compare hs-Gal4 to hs-Gal4;UAS-dRYBP) and does not significantly change when two UAS constructs are concomitantly
expressed (compare hs-Gal4;UAS-dRYBP to hs-Gal4,UAS-imd/UAS-dRYBP). (C) shows qRT-PCR quantification of mRNA levels of imd expression. imd
expression is increased under induced conditions (compare hs-Gal4 to hs-Gal4,UAS-imd) and does not significantly change when two UAS constructs
are concomitantly expressed (compare hs-Gal4,UAS-imd to hs-Gal4,UAS-imd/UAS-dRYBP). (D) dRYBP acts downstream of Relish. Flies overexpressing
dRYBP, Rel (Relish-His-6), or both under the control of a heat-shock-inducible promoter were kept at 18uC, which induces low overexpression of all
constructs. Dpt mRNA levels were assessed as a measure of Relish-dependent transcriptional activation. (E) qRT-PCR quantification of mRNA levels of
dRYBP expression in the same crosses. dRYBP expression is increased when overexpressed with hs-Gal4 in flies kept at 18uC (compare hs-Gal4 to hs-
Gal4;UAS-dRYBP) and does not significantly change when two UAS constructs are concomitantly expressed (compare hs-Gal4;UAS-dRYBP to hs-Gal4/
UAS-Relish-His-6;UAS-dRYBP). (F) dRYBP acts upstream of SKPA. Flies overexpressing dRYBP, RNAi against skpA, or both under the control of the fat-
body specific driver c564-Gal4 were either kept at 18uC (OFF) or shifted to 29uC for 24 h (ON), at which point Dpt mRNA levels were assessed to
measure Imd pathway activity. (G) qRT-PCR quantification of mRNA levels of dRYBP expression. dRYBP expression is increased under induced
conditions (compare c564-Gal4 to c564-Gal4;UAS-dRYBP) and does not significantly change when two UAS constructs are concomitantly expressed
(compare c564-Gal4;UAS-dRYBP to c564-Gal4;UAS-dRYBP/UAS-skpARNAi). Asterisks denote the following p values: *, 0.01,p,0.05; **, 0.001,p,0.01;
*** p,0.001; ns, not significant. Data represent mean + SEM of 3 biological repeats.
doi:10.1371/journal.pone.0062052.g004
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fore likely that dRYBP might exert its regulatory role through
interaction with proteins that are either ubiquitylated themselves
or play a role in ubiquitylation. A search for dRYBP-interacting
proteins by mass spectrometry (Simo´n et al., manuscript in
preparation and Fig. S2A) has shown that in unchallenged
conditions the dRYBP protein physically interacts with CULLIN-
1 and SKPA proteins, both members of the E3-ubiquitin ligase
SCF complex that targets substrates to the 26S proteasome and
plays a pivotal role in regulating diverse developmental events
[56–59]. Members of the SCF-E3 ubiquitin ligase complex, in
particular SKPA, CULLIN-1 and SLIMB, have been previously
reported to function as repressors of AMP production in
uninfected flies [26] and proposed to repress the Imd pathway
by promoting the ubiquitylation and subsequent degradation of a
constitutively active Relish protein, as well as down-regulating
AMP production after infection in vivo [26]. Our epistatic genetic
interaction analysis (Fig. 4) demonstrates that dRYBP functions
either together with or downstream of Relish, and together with or
upstream of SKPA to dampen the activated immune response.
Based on the epistatic and proteomic data, it is likely that dRYBP
associates with the SCF-E3 ubiquitin ligase complex to inhibit the
activated immune response at the level of Relish degradation.
We propose that dRYBP functions as a ubiquitin adaptor
protein in the regulation of the Imd pathway. dRYBP may
contribute to the termination of Imd pathway activation by
promoting assembly of the SCF complex, which is known to
ensure degradation of Relish [26]. Of note, the observed
haploinsufficiency of dRYBP (Fig. 1) would suggest that complex
assembly is sensitive to the stoichiometry of its components.
However, the fact that dRYBP null mutants show a normal return
to baseline suggests that dRYBP is non-essential in shutting off
signaling, and contributes to the amplitude rather than the
duration of signaling output. In the complete absence of dRYBP,
failure to assemble the SCF complex correctly and timely would
lead to transient accumulation of activated nuclear Relish and to
excessive transcription of Relish-dependent genes.
The vertebrate homolog of Relish, the NF-kB subunit p105
protein, has been demonstrated both to be ubiquitylated and to
belong to the superfamily of DD (Death Domain) containing
proteins [60]. The latter plays important roles in the assembly and
activation of apoptotic and inflammatory complexes [36].
Curiously, the Drosophila RYBP protein and the vertebrate
RYBP/DEDAF/YAF2 protein have been shown to interact with
Death Effector Domain (DED) proteins, a subfamily of the DD
proteins [31,32,36]. A search for a DD domain in the Relish
protein using the Death Domain Database (www.deathdomain.
org) [61] returned that indeed Relish contains a putative DD
domain with a relevant percentage of similarity to the DD in
mammalian p105 (Fig. S2B, C) [62]. Possibly, the interaction
between Relish and dRYBP involves both the DD binding domain
and ubiquitin signatures on Relish to promote its proteasomal
degradation through the SKPA/Cullin complex. It now remains
to be clarified whether and how dRYBP interacts with Relish upon
infection and whether dRYBP has an effect on the degradation of
Relish. At this stage, we cannot exclude that dRYBP might also
function at other steps in this pathway, including in the process of
ubiquitylation of the IMD protein [17,19], to negatively regulate
the immune response.
The present work has shown that dRYBP contributes to the
regulation of the fly immune response, a fundamental systemic
organism reaction to overcome external harm or stress. The
decision to repress the activated immune response likely depends
on the nature of the stress signal. Further investigations will shed
light on the contribution of dRYBP in reaching a balanced
immune response and will reveal whether the evolutionarily
conserved RYBP protein may have a novel function in the control
of the human innate immune response.
Supporting Information
Figure S1 The dRYBP loss of function phenotype is modulated
by mutant alleles of the Imd pathway. (A) Crossing scheme. The
engrailed-Gal4 (en-Gal4) driver was used to express UAS-dRYBPRNAi
and UAS-VDRCRNAi in the wing. Female virgins en-Gal4/
CyO;UAS-dRYBPRNAi /MKRS were crossed with males UAS-
VDRCRNAi and maintained at 29uC. From these crosses, the en-
Gal4;UAS-VDRCRNAi progeny were analyzed for wing phenotypes
associated with the particular VDRCRNAi line under study and the
en-Gal4;UAS-dRYBPRNAi,/UAS-VDRCRNAi progeny were analyzed
for the penetrance of the wing blister phenotype. (B) Wild-type
wing. (C) en-Gal4.dRYBPRNAi wing showing a blister (arrow) in the
posterior compartment. (D) Quantification of flies with wing
blisters of the indicated genotypes. en-Gal4.dRYBPRNAi/UAS-GFP
was used as a control. Importantly, this screen merely shows
genetic interaction between dRYBP and Imd pathway compo-
nents. It is not yet clear why the penetrance of blister phenotype in
our screen can be modulated by mutations in genes involved in the
innate immune response or why the penetrance is modulated by
mutations in both activators and repressors of the Imd pathway.
The wing phenotypes are probably due to these factors involved in
other biological processes [38,63].
(TIF)
Figure S2 Mass spectrometry data and localization of a Death
Domain in the Relish protein. (A) Mass spectrometry results
showing the scores for the indicated dRYBP interacting proteins.
(B) Alignment of Human p105 and Drosophila Relish protein
sequence. Indicated in green is the predicted Death Domain (DD)
sequence (www.deathdomain.org). (C) Magnification of the
predicted DD domain. (D) Alignment of other DD containing
proteins with the predicted DD domain in the Relish proteins.
(TIF)
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